| Final Recommendation Statement: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults |
|
| Final Recommendation Statement: Interventions to Prevent Falls in Community-Dwelling Older Adults |
|
| AHRQ Seeks Nomination of New Members to the U.S. Preventive Services Task Force |
|
| Final Recommendation Statement: Behavioral Counseling to Prevent Skin Cancer |
|
| Public Comment on Draft Research Plan: Interventions for Tobacco Cessation in Adults, Including Pregnant Women |
|
| Announcement of New U.S. Preventive Services Task Force Chair, Vice Chair, and Member |
|
| Public Comment on Draft Research Plan: Screening for Bacterial Vaginosis in Pregnant Women to Prevent Preterm Delivery |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review Interventions to Prevent Obesity-Related Morbidity and Mortality |
|
| Final Recommendation Statement: Screening for Ovarian Cancer |
|
| Final Research Plan: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum |
|
| U.S. Preventive Services Task Force Announces Appointment of Two New Members |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Syphilis Infection in Pregnant Women |
|
| Public Comment on Two Draft Recommendation Statements and Draft Evidence Reviews: Screening for PAD and CVD Risk Assessment With the ABI and Risk Assessment for CVD With Nontraditional Risk Factors |
|
| Final Recommendation Statement: Screening for Adolescent Idiopathic Scoliosis |
|
| Final Research Plan: Screening for Asymptomatic Bacteriuria in Adults |
|
| Final Research Plan: Screening for Hepatitis C Virus Infection in Adolescents and Adults |
|
| Public Comment on Two Draft Recommendation Statements and Draft Evidence Reviews: Screening for CVD Risk With ECG and Screening for Atrial Fibrillation With ECG |
|
| 2016 Report to Congress |
|
| AJPM Publishes Special Issue on U.S. Preventive Services Task Force Methods |
|
| Final Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women |
|
